United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
284.73
-0.46 (-0.16%)
Apr 17, 2025, 4:00 PM EDT - Market closed
United Therapeutics Market Cap
United Therapeutics has a market cap or net worth of $12.79 billion as of April 17, 2025. Its market cap has increased by 17.54% in one year.
Market Cap
12.79B
Enterprise Value
8.38B
1-Year Change
17.54%
Ranking
Category
Stock Price
$284.73
Market Cap Chart
Since June 17, 1999, United Therapeutics's market cap has increased from $185.60M to $12.79B, an increase of 6,790.00%. That is a compound annual growth rate of 17.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2025 | 12.79B | -18.82% |
Dec 31, 2024 | 15.75B | 52.44% |
Dec 29, 2023 | 10.33B | -18.47% |
Dec 30, 2022 | 12.67B | 30.24% |
Dec 31, 2021 | 9.73B | 44.26% |
Dec 31, 2020 | 6.75B | 74.53% |
Dec 31, 2019 | 3.87B | -18.57% |
Dec 31, 2018 | 4.75B | -25.75% |
Dec 29, 2017 | 6.39B | 5.09% |
Dec 30, 2016 | 6.08B | -14.87% |
Dec 31, 2015 | 7.15B | 16.16% |
Dec 31, 2014 | 6.15B | 8.32% |
Dec 31, 2013 | 5.68B | 109.29% |
Dec 31, 2012 | 2.71B | -1.54% |
Dec 30, 2011 | 2.76B | -23.40% |
Dec 31, 2010 | 3.60B | 26.94% |
Dec 31, 2009 | 2.83B | 95.09% |
Dec 31, 2008 | 1.45B | -30.01% |
Dec 31, 2007 | 2.08B | 64.45% |
Dec 29, 2006 | 1.26B | -20.99% |
Dec 30, 2005 | 1.60B | 58.72% |
Dec 31, 2004 | 1.01B | 105.98% |
Dec 31, 2003 | 488.70M | 39.91% |
Dec 31, 2002 | 349.30M | 65.94% |
Dec 31, 2001 | 210.50M | -29.29% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 679.94B |
UnitedHealth Group | 533.82B |
Johnson & Johnson | 370.25B |
AbbVie | 312.76B |
Novo Nordisk | 286.28B |
Abbott Laboratories | 218.91B |
AstraZeneca | 210.97B |
Novartis AG | 209.02B |